[Therapeutic effect of gefin, a new antiviral drug, in experimental genital herpes ]. / Lechebnoe deistvie novogo protivovirusnogo preparata gefina pri éksperimental'nom genital'nom gerpese.

Antiviral activity of Gefin was studied in guinea pigs infected with herpes simplex virus (HSV-2). Up to 54.9% animals challenged with HSV survived after 7-day treatment with Gefin (3 local applications a day). The prospects of further trials of the drug in HSV genital herpes are discussed.

[Evaluation of antiviral activity of new medicinal forms of foscarnet in genital herpes in guinea pigs]. / Otsenka protivovirusnoi aktivnosti novykh lekarstvennykh form foskarneta pri genital'nom gerpese morskikh svinok.

Antiviral activity of a Russian drug foscarnet (tablets and coated pills) was assessed in guinea pigs with experimental genital herpes. New dosage forms were well tolerated by the animals, causing no manifest symptoms of intoxication irrespective of the doses or protocols of the drug use, Foscarnet in any dosage form in the total daily dose of at least 120 mg/kg had a pronounced antiviral effect towards herpes simplex type II virus, comparable with that of the commercial reference drug virolex: the intensity of clinical symptoms was alleviated and the disease duration shortened.